Weiss Ratings Reiterates "Hold (C)" Rating for Axon Enterprise (NASDAQ:AXON)

Key Points

• Weiss Ratings has reiterated a "hold (C)" rating for Axon Enterprise (NASDAQ:AXON), while several other analysts have set higher target prices and ratings, indicating mixed sentiment among investors.
• Axon Enterprise's stock recently traded at $735.95 with a market cap of $57.77 billion, reflecting a significant trading volume of 383,647 shares.
• In its latest earnings report, Axon surpassed analysts' expectations with an EPS of $2.12 and revenue of $668.54 million, marking a year-over-year revenue increase of 32.6%.

Axon Enterprise (NASDAQ:AXON - Get Free Report)'s stock had its "hold (c)" rating reiterated by Weiss Ratings in a research note issued on Friday,Weiss Ratings reports.

AXON has been the topic of a number of other research reports. Bank of America raised their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. Piper Sandler began coverage on Axon Enterprise in a report on Tuesday, September 23rd. They issued an "overweight" rating and a $893.00 target price on the stock. Craig Hallum raised Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 target price on the stock in a report on Tuesday, August 5th. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $870.00 target price on shares of Axon Enterprise in a report on Wednesday, September 24th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and a consensus target price of $841.64.

Axon Enterprise Stock Performance

AXON traded up $19.56 during midday trading on Friday, reaching $735.95. The company's stock had a trading volume of 383,647 shares, compared to its average volume of 672,012. The stock has a market cap of $57.77 billion, a P/E ratio of 181.72, a PEG ratio of 27.23 and a beta of 1.41. The company has a fifty day simple moving average of $733.54 and a 200 day simple moving average of $722.15. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise has a twelve month low of $422.38 and a twelve month high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company's revenue was up 32.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts expect that Axon Enterprise will post 5.8 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at approximately $2,538,744,696.78. The trade was a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Brittany Bagley sold 5,000 shares of the business's stock in a transaction dated Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the transaction, the chief financial officer directly owned 93,592 shares of the company's stock, valued at approximately $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 59,932 shares of company stock worth $45,115,616 over the last three months. 4.40% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. TCI Wealth Advisors Inc. acquired a new position in Axon Enterprise in the second quarter valued at about $214,000. Duncker Streett & Co. Inc. boosted its position in shares of Axon Enterprise by 3.2% during the second quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company's stock worth $12,006,000 after buying an additional 448 shares during the period. Quotient Wealth Partners LLC acquired a new position in shares of Axon Enterprise during the first quarter worth about $438,000. GAMMA Investing LLC boosted its position in shares of Axon Enterprise by 11.8% during the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company's stock worth $765,000 after buying an additional 154 shares during the period. Finally, DAVENPORT & Co LLC boosted its position in shares of Axon Enterprise by 5.1% during the first quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company's stock worth $494,000 after buying an additional 46 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.